Generics 16

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Zolmitriptan manufacturers

16 products found

Filters

16 products found

zolmitriptan

Tablets, orally disintegrating (ODT) 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Estonia , Germany , Latvia , Lithuania , United Kingdom , Vietnam
Available for
Distribution only
Comments
Ref. Zomig
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

zolmitriptan

Tablets 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Unavailable markets
Germany , United Kingdom , Vietnam
Available for
Distribution only
Comments
Ref. Zomig
Manufacturer #269
A pharmaceutical manufacturer based in the EU that is active in 100+ countries selling its products in Europe, North America, Africa, the Middle East, and Asia for 40+ years. Main therapeutic areas include CNS, cardiovascular medication, and anti-infectives. The company's production lines are EU GMP-compliant. Key production lines are Rx and OTC. The company owns 20+ branches in Europe, Africa, and Asia.

Manufacturer usually replies in 5 days

zolmitriptan

Tablets, orally disintegrating (ODT) 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Austria , Belgium , Bulgaria , Croatia , Cyprus , Czech Republic , Denmark , Estonia , Finland , France , Germany , Greece , Italy , Latvia , Liechtenstein , Lithuania , Luxembourg , Malta , Netherlands , Norway , Poland , Portugal , Spain , Sweden , United Kingdom , Vietnam
Available for
Licensing with supply, Distribution only
Manufacturer #573
A pharmaceutical manufacturer based in the EU that has been active in 50+ countries selling its products in Europe, North America, LATAM, Africa, and Asia for 30+ years. Key production lines are Rx and nutraceuticals. Main therapeutic areas include CNS and respiratory. Main dosage forms include sterile forms and oral solid. The company's production lines are EU GMP-compliant. The company owns 10+ branches in Europe.

Manufacturer usually replies in 7 days

zolmitriptan

Nasal spray 2.5 mg, 5 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Zomig®
Manufacturer #252

Manufacturer usually replies in 2 days

zolmitriptan

Tablets, orally disintegrating (ODT) 2,5mg, 5mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Spain , Germany , Poland , Czech Republic , Slovakia , Romania , Netherlands
Manufacturer #6978

Manufacturer usually replies in 3 days

zolmitriptan

Tablets 2,5mg, 5mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
United Kingdom , Spain , Germany , Slovakia , Czech Republic , Poland , Romania , Netherlands
Manufacturer #6978

Manufacturer usually replies in 3 days

zolmitriptan

Tablets, orally disintegrating (ODT) 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17783
It is a pharmaceutical company that began operations in the 2000s in North America and sells a wide selection of generic pharmaceuticals while continuing to expand its portfolio. They try to deliver accessible solutions for patient safety through continuing innovation such as simpler packaging and important safety features. They are laser-focused on developing cutting-edge solutions to ensure that patients have access to high-quality pharmaceuticals.

Manufacturer usually replies in 9 days

zolmitriptan

Tablets 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Canada
GMP approvals
Canada
Manufacturer #17783
It is a pharmaceutical company that began operations in the 2000s in North America and sells a wide selection of generic pharmaceuticals while continuing to expand its portfolio. They try to deliver accessible solutions for patient safety through continuing innovation such as simpler packaging and important safety features. They are laser-focused on developing cutting-edge solutions to ensure that patients have access to high-quality pharmaceuticals.

Manufacturer usually replies in 9 days

zolmitriptan

Tablets 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Unavailable markets
Iraq , Kazakhstan , Ukraine , Uzbekistan , Vietnam
Comments
RX
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

zolmitriptan

Tablets 2.5mg, 5mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #9258

Manufacturer usually replies in 4 days

zolmitriptan

Tablets 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Pakistan
GMP approvals
Sri Lanka, Afghanistan, Vietnam, Cambodia, Myanmar
Manufacturer #21102

Manufacturer usually replies in 5 days

zolmitriptan

Tablets 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA
Manufacturer #18353

Manufacturer usually replies in 10 days

zolmitriptan

Nasal spray 2.5 mg/dose, 5 mg/dose - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Ukraine
GMP approvals
EU GMP
Comments
RX
Manufacturer #15907
A world leader in the production and maintenance of medicines as well as a leading exporter with a proven track record of exporting to more than 40 countries. High quality and constant innovation have proven to be the biggest achiever here.

Manufacturer usually replies in 8 days

zolmitriptan

Tablets 5 mg, 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan, EU GMP
Manufacturer #20767
It is a multinational pharmaceutical company specializing in the development, production, and distribution of generic and specialty medicines. They have a broad technology base covering OSD, liquids, creams, ointments, and sterile (injectable) across all key therapeutic areas. They have a further 90+ products (INNs) under development and registration. They aim to improve the quality of life by increasing access to high-quality and affordable medicines.

Manufacturer usually replies in 11 days

zolmitriptan

Tablets 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
Canada
Manufacturer #17753

Manufacturer usually replies in 10 days

zolmitriptan

Nasal spray 5 mg - 10 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO, PICS, Cambodia, Ethiopia, Tanzania, Yemen
Registered in
Mauritius , Moldova , Myanmar , Tanzania
Available for
Licensing with supply
MAs for sale
India , Ivory Coast , Mauritius , Myanmar
Manufacturer #20282

Manufacturer usually replies in 23 days

Zolmitriptan is a medication used to treat severe migraines. Suppliers of zolmitriptan market it in the form of 2.5mg and 5mg tablets, as well as nasal sprays. Alternatives to zolmitriptan are other triptan class medications, namely, sumatriptan, naratriptan, rizatriptan, almotriptan, eletriptan, and frovatriptan. The drug was first introduced into the pharmaceutical market in 1997 and has since then become approved in over 100 countries globally, including but not limited to geographical markets China, Australia, Japan, Brazil, as well as across Europe. The largest manufacturers and suppliers of zolmitriptan medications are companies Sun Pharmaceuticals, Teva, and AstraZeneca. Following patent expiry in 2013, other manufacturers launched their generic formulations of zolmitriptan. Buyers are advised that online sellers may attempt to market fraudulent versions of the generic drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified zolmitriptan manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform. Retail prices for 6 (2.5mg) tablets of zolmitriptan are approximately 30 EUR to 40 EUR.